01.23.26 -- A Deeper Look At Pharma's Structural Supply Chain Vulnerability

Facility shutdowns often compromise contamination control strategies. Transitioning from manual cleaning to automated bio-decontamination ensures a more effective facility restart.

Although most legislation concerning the traceability of pharma products focuses on serialization rather than aggregation, the latter is an essential component of internal and external traceability of products.

Watch to discover transformative opportunities in the Life Sciences industry as well as explore trends and learn how to unify digital quality and manufacturing processes to stay ahead in this dynamic field.

Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.

By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.

Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.

Learn how a biodegradable polymer platform that is compatible with many substrates can enable several applications as a drug eluting carrier with a wide variety of APIs.

A sponsor’s commitment to rigorous impurity control throughout manufacturing is vital to ensuring continuous patient safety. E&Ls, nitrosamines, and PFAS are among the most critical impurities.

Uncover how deep technical knowledge, unmatched capabilities, and a proven safety culture can help protect your process at every stage.

In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Examine the potential benefits supported by case studies.

GMP compliance requires monitoring microbial contamination levels in cleanrooms and clean spaces. It is important to know the role active air samplers play in this process and parameters for evaluating them.

Combining innovative technologies enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.